摘要
我国糖尿病患病率已达到9.7%。优化血糖控制均可减少1型糖尿病(T1DM)和2型糖尿病(T2DM)远期并发症的发生。最近UKPDS的后序随访数据结果提示胰岛素治疗降低了T2DM患者大血管的发病风险。目前糖尿病治疗中多建议在确诊后首先采用生活方式干预联合二甲双胍控制血糖,在疗效不佳时可选用磺脲类、格列奈类或基础胰岛素治疗.
出处
《中国糖尿病杂志》
CAS
CSCD
北大核心
2010年第4期318-319,共2页
Chinese Journal of Diabetes
参考文献26
-
1Yang W,Lu J,Weng J,et al.Prevalence of diabetes among men and women in China.N Engl J Med,2010,362:1090-1101.
-
2Gaede P,Lund-Andersen H,Parving HH,et al.Effect of a multifactorial intervention on mortality in type 2 diabetes.N Engl J Med,2008,358:580-591.
-
3Holman RR,Paul SK,Bethel MA,et al.10-year follow-up of intensive glucose control in type 2 diabetes.N Engl J Med,2008,359:1577-1589.
-
4Nathan DM,Buse JB,Davidson MB,et al.Medical management of hyperglycemia in type 2 diabetes:a consensus algorithm for the initiation and adjustment of therapy:a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.Diabetes Care,2009,32:193-203.
-
5Halperin F,Ingelfinger JR,McMahon GT.Clinical decisions.Management of type 2 diabetes-polling results.N Engl J Med,2008,358:E8.
-
6Wutte A,Plank J,Bodenlenz M,et al.Proportional dose-response relationship and lower within-patient variability of insulin detemir and NPH insulin in subjects with Type 1 diabetes mellitus.Exp.Clin.Endocrinol.Diabetes,2007,115:461-467.
-
7Plank J,Bodenlenz M,Sinner F,et al.A double-blind,randomized,dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir.Diabetes Care,2005,28:1107-1112.
-
8Klein O,Lynge J,Endahl L,et al.Albuminbound basal insulin analogues (insulin detemir and NN344):comparable time-action profiles but less variability than insulin glargine in Type 2 diabetes.Diabetes Obes Metab,2007,9:290-299.
-
9Heise T,Pieber TR.Towards peakless,reproducible and long-acting insulins.An assessment of the basal analogues based on isoglycaemic clamp studies.Diabetes Obes Metab,2007,9:648-659.
-
10Havelund S,Plum A,Ribel U,et al.The mechanism of protraction of insulin detemir,a long-acting,acylated analog of human insulin.Pharm Res,2004,21:1498-504.
同被引文献11
-
1Rodbard HW, Blonde L, Braithwaite S8,etal. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus[J]. Endocr Praet,2007,15(Suppl 1): 1-68.
-
2PhiLLies-Tsimikas A.An update on tha use of insulin detemir,with a focus on type 2 diabetes(drug evaluation updtee)[J].Expert Opin Pharmscoth er,2008,9(12):2181-2195.
-
3Klein O, Lynge J, Endahl L, et al, Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but lessvariability than insulin glargine in type 2 diabetes[J], Diabetes Obes Metab, 2007,9 ( 5 ) : 290-299.
-
4Rosenstock J,Davies M,Home PD,et al.A randomized,52-week, treat-to-target trail comparing insulin detemir with insulin glargine when administer"as add-on to glucose_loweringdrugs in insulin.naulive people with Type 2 diabetes.Diabetologia,2008(3),51:408-416.
-
5Philis-Tsimikas A,Charpentier G,Olauson P,et al. Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes [J].Clin Ther,2006,28(10):1569-1581.
-
6Blonde L,Merillinen M,Karwe V,et al. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITEATE study [J].Diabetes Obes Metab,2009, 11(6): 625-651.
-
7卢艳慧.地特胰岛素的葡萄糖钳夹研究进展[J].药物评价,2009(4):159.
-
8Mornnier L,Colette C,Mas E,et al.Eegulation of oxidative stress by glycaemic control:Evidence for an independent inhibitory effect of insulin therapy[J]. Diabetologia, 201 O, 53(3): 562-571.
-
9Domhorst A,Luddeke HJ,Honka M,et a1.Safety arid efficacy of insutin detemjr basal-bolus therapy in Type I diabetesprtients:1 4-week data from the European cohort of the PREDICTIVE study[J].Curr Med Res Opin, 2008,24(2): 369-576.
-
10Luddeke HJ,sreenana S,Aczel s,et al. PREDIcTIVE-aglobal, prospective observational study to evaluate insulin detemfr treatment in Typesland2diabetes:baseline characteristics and predictors of hypoglycaemia from the European cohort[J].Diabet obes Metab,2007,9(5):428-454.
-
1张杰.糖尿病患者服用降糖药物的指导[J].社区医学杂志,2009,7(24):17-18.
-
2杨燕,童南伟.2011年《中国成人2型糖尿病胰岛素促泌剂应用的专家共识》解读[J].中国实用内科杂志,2012,32(3):191-193. 被引量:13
-
3张清贵.谈谈口服降糖药物的作用及合理选择[J].糖尿病新世界,2004(1):40-41.
-
4林少达.怎样选择胰岛素促泌剂?[J].糖尿病之友,2007(4):52-52.
-
5徐庆海.2型糖尿病的药物治疗研究进展[J].医疗装备,2017,30(4):191-192. 被引量:8
-
6冯凭(执笔).格列吡嗪控释片治疗2型糖尿病有效性和安全性的多中心临床研究[J].国际内分泌代谢杂志,2011,31(2):73-76. 被引量:7
-
7蒋骅.头孢类药物联合喹诺酮序贯治疗老年人社区获得性肺炎的疗效观察[J].临床合理用药杂志,2012,5(12):53-54. 被引量:5
-
8陈瑛.院外对AMI患者溶栓治疗的探讨[J].井冈山医专学报,2007,14(1):39-40. 被引量:5
-
9李东.双水平正压机在急性重度有机磷农药中毒有创通气后脱机过渡中的应用价值[J].中国实用医刊,2009,36(13):1-3.
-
10孙凯,袁超,陈旭锋,李琳,张劲松.中危肺血栓栓塞症溶栓治疗效果分析[J].南京医科大学学报(自然科学版),2016,36(12):1478-1480. 被引量:1